Identification of phospholipase A2 inhibitors in A.beta. peptide-mediated neurodegenerative disease
US5707821A · kind A · utility
22Cited by
6References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 1995 |
| Grant date | Jan 13, 1998 |
| Priority date | — |
| Expiry date | Jun 7, 2015 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides methods and compositions for treating neurodegeneration in mammalian cells by administering a phospholipase A2 inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.